-
Entity
-
Company
-
Location
-
C/O Kohlberg Kravis Roberts & Co. L.P., 9 West 57 Th Street, Suite 4200, New York, NY
-
Summary
-
The estimated value of insider holdings of KKR Genetic Disorder L.P. is at least $650M dollars as of September 17, 2024. KKR Genetic Disorder L.P. is the 10%+ Owner of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $650M.